Cargando…
Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector
Gaucher disease type 1 (GD1) is an inherited lysosomal disorder with multisystemic effects in patients. Hallmark symptoms include hepatosplenomegaly, cytopenias, and bone disease with varying degrees of severity. Mutations in a single gene, glucosidase beta acid 1 (GBA1), are the underlying cause fo...
Autores principales: | Dahl, Maria, Smith, Emma M.K., Warsi, Sarah, Rothe, Michael, Ferraz, Maria J., Aerts, Johannes M.F.G., Golipour, Azadeh, Harper, Claudia, Pfeifer, Richard, Pizzurro, Daniella, Schambach, Axel, Mason, Chris, Karlsson, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806948/ https://www.ncbi.nlm.nih.gov/pubmed/33511245 http://dx.doi.org/10.1016/j.omtm.2020.11.018 |
Ejemplares similares
-
Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34+ cord blood hematopoietic stem cells using a clinically applicable lentiviral vector
por: Liu, Yang, et al.
Publicado: (2021) -
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency
por: Poletti, Valentina, et al.
Publicado: (2018) -
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
por: Charrier, Sabine, et al.
Publicado: (2019) -
Engineered human Diamond-Blackfan anemia disease model confirms therapeutic effects of clinically applicable lentiviral vector at single-cell resolution
por: Liu, Yang, et al.
Publicado: (2023) -
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
por: Poletti, Valentina, et al.
Publicado: (2018)